Cold and flu season is upon us. Treating and alleviating the common cold can be challenging — but Enzymatica has discovered something that might change that!Enzymatica AB is a Swedish consumer biotech company that has made a genuine technological breakthrough that could change the future of self-care. It gives hope that in the future, people will have a totally new ability to protect themselves from airborne viruses that cause upper respiratory tract infections like cold and flu and potentially shorten the symptoms of the infection.It works by forming a barrier that traps the viruses so viruses can't attach to and infect human cells. The barrier deactivates the viruses and stops them from sticking. It is applied as a convenient, fast-acting mouth spray that creates an enzyme barrier. This shield protects people directly, even at the first signs of a cold or flu, defending the body from continued viral attachment.
